methadone has been researched along with indinavir sulfate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berthou, F; Carlhant, D; Dreano, Y; Iribarne, C; Lohezic, F; Picart, D; Riche, C | 1 |
| de la Cruz Pellín, M; Esteban, J; Gimeno, C; Mora, E | 1 |
| Bedynek, PS; Hoffer, C; Kharasch, ED; Walker, A; Whittington, D | 2 |
| Firląg-Burkacka, E; Grycner, E; Horban, A; Kowalska, JD; Matłosz, B; Pietraszkiewicz, E | 1 |
1 review(s) available for methadone and indinavir sulfate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for methadone and indinavir sulfate
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors.
Topics: Alkylation; Buprenorphine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; HIV Protease Inhibitors; Humans; Indinavir; Kinetics; Methadone; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Ritonavir; Saquinavir | 1998 |
[Interaction between methadone and antiretrovirals (stavudine, indinavir, ritonavir, nevirapine)].
Topics: Anti-HIV Agents; Drug Interactions; Female; Humans; Indinavir; Male; Methadone; Narcotics; Nevirapine; Ritonavir; Stavudine; Substance Withdrawal Syndrome | 2003 |
Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport: insights from methadone interactions with ritonavir/indinavir.
Topics: Adolescent; Adult; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Enzyme Activation; Female; Gastrointestinal Tract; Humans; Indinavir; Intestinal Absorption; Male; Methadone; Ritonavir; Young Adult | 2009 |
Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A).
Topics: Adolescent; Adult; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Indinavir; Intestines; Liver; Male; Metabolic Clearance Rate; Methadone; Young Adult | 2012 |
Risk factors for kidney disease among HIV-1 positive persons in the methadone program.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Indinavir; Kidney Diseases; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Poland; Risk Factors; Sex Factors; Tenofovir; Time Factors | 2019 |